Cite
Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe.
MLA
Vreman, Rick A., et al. “Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe.” Clinical Pharmacology & Therapeutics, vol. 108, no. 2, Aug. 2020, pp. 350–57. EBSCOhost, https://doi.org/10.1002/cpt.1835.
APA
Vreman, R. A., Naci, H., Goettsch, W. G., Mantel, T. A. K., Schneeweiss, S. G., Leufkens, H. G. M., & Kesselheim, A. S. (2020). Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe. Clinical Pharmacology & Therapeutics, 108(2), 350–357. https://doi.org/10.1002/cpt.1835
Chicago
Vreman, Rick A., Huseyin Naci, Wim G. Goettsch, Teeuwisse, Aukje K. Mantel, Sebastian G. Schneeweiss, Hubert G. M. Leufkens, and Aaron S. Kesselheim. 2020. “Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe.” Clinical Pharmacology & Therapeutics 108 (2): 350–57. doi:10.1002/cpt.1835.